Share
CNBC Pro

Watch CNBC's full interview with J&J CFO on Q1 2021 earnings, vaccine pause

Johnson & Johnson on Tuesday reported $100 million in first-quarter sales of its Covid-19 vaccine that’s on hold in the U.S. while U.S. health regulators investigate a rare blood-clotting issue. Johnson & Johnson CFO Joseph Wolk joins CNBC's Meg Tirrell to discuss the quarterly results as well as the pause of the company's vaccine in the United States due to safety concerns.
08:05
Tue, Apr 20 20217:21 AM EDT

watch now
VIDEO04:23
CNBC ProHSBC's chief global strategist picks asset classes to avoid flattened returns
watch now
VIDEO02:38
CNBC ProWedbush Securities analyst weighs in on Uber vs Lyft
watch now
VIDEO45:08
CNBC ProMad Money with Jim Cramer — May 5, 2021
watch now
VIDEO44:03
CNBC ProFast Money — May 5, 2021
watch now
VIDEO08:15
CNBC ProPagerDuty CEO: Hybrid workplace means more complexities for companies